{"context":{"query":"PSORIASIS"},"stats":{"total":50},"pagination":{"has_next":true,"next_token":"0,0,-1,50"},"schema":"id|dataset|name|xref_count","data":["Q9UIG5|uniprot|Psoriasis susceptibility 1 candidate gene 1 protein|1508","Q7YR46|uniprot|Psoriasis susceptibility 1 candidate gene 1 protein homolog|58","Q7YR45|uniprot|Psoriasis susceptibility 1 candidate gene 2 protein homolog|52","Q80ZC9|uniprot|Psoriasis susceptibility 1 candidate gene 2 protein homolog|720","Q9UIG4|uniprot|Psoriasis susceptibility 1 candidate gene 2 protein|1763","338|pubchem|Salicylic Acid|86635","D015535|mesh|Arthritis, Psoriatic|3960","D011565|mesh|Psoriasis|6439","C536978|mesh|Tranebjaerg Svejgaard syndrome|2","EFO:0000676|efo|psoriasis|3504","EFO:0003778|efo|psoriatic arthritis|2156","EFO:0007773|efo|cutaneous psoriasis measurement|1182","EFO:0022382|efo|psoriasis area and severity index|1172","EFO:1001494|efo|psoriasis vulgaris|1973","MONDO:0013554|mondo|psoriasis 13, susceptibility to|1175","MONDO:0012896|mondo|psoriasis 10, susceptibility to|1168","MONDO:0100491|mondo|generalized pustular psoriasis|1376","MONDO:0005083|mondo|psoriasis|1180","MONDO:0008334|mondo|psoriasis 1, susceptibility to|1169","MONDO:0010652|mondo|X-linked intellectual disability-seizures-psoriasis syndrome|1384","MONDO:0011084|mondo|psoriasis 3, susceptibility to|1168","MONDO:0011269|mondo|psoriasis 2|2309","MONDO:0011387|mondo|psoriasis 4, susceptibility to|1168","MONDO:0011434|mondo|psoriasis 5, susceptibility to|1168","MONDO:0011542|mondo|psoriasis 6, susceptibility to|1168","MONDO:0011573|mondo|psoriasis 7, susceptibility to|1170","MONDO:0011849|mondo|psoriatic arthritis|1889","MONDO:0011926|mondo|psoriasis 9, susceptibility to|1168","MONDO:0012542|mondo|psoriasis 8, susceptibility to|1168","MONDO:0100171|mondo|psoriasis, susceptibility to|1180","MONDO:0012959|mondo|psoriasis 11, susceptibility to|1168","MONDO:0013057|mondo|psoriasis 12, susceptibility to|1168","MONDO:0023297|mondo|guttate psoriasis|1169","MONDO:0013626|mondo|psoriasis 14, pustular|1263","MONDO:0014494|mondo|psoriasis 15, pustular, susceptibility to|1173","MONDO:0015597|mondo|pustulosis palmaris et plantaris|1198","MONDO:0022205|mondo|pustular psoriasis|1182","HP:0003765|hpo|Psoriasiform dermatitis|143","64267|entrez|ATPase Na+/K+ transporting subunit beta 1a|287","404546|orphanet|DITRA|6","163927|orphanet|Pustulosis palmaris et plantaris|5","163931|orphanet|Acrodermatitis continua of Hallopeau|27","3052|orphanet|X-linked intellectual disability-seizures-psoriasis syndrome|8","40050|orphanet|NON RARE IN EUROPE: Psoriatic arthritis|1","247353|orphanet|Generalized pustular psoriasis|222","NM_131668|refseq||5","GCST000322|gwas_study||9","GCST90013935|gwas_study||1","GCST001473|gwas_study||243","GCST002738|gwas_study||21"]}